Cellosaurus GOTO (CVCL_1234)

Cell line name GOTO
Accession CVCL_1234
Resource Identification Initiative To cite this cell line use: GOTO (RRID:CVCL_1234)
Comments Doubling time: ~48 hours (PubMed=470188).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Disease Neuroblastoma (NCIt: C3270)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children: CVCL_2911 (GOTO.P3)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; JCRB

Markers:
AmelogeninX
CSF1PO10,12
D13S31715
D16S53911,13
D5S81811,12
D7S8208,11
TH019
TPOX11
vWA17,19 (Cosmic-CLP)
18,19 (JCRB)
Web pages http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-564.html
Publications

PubMed=470188
Sekiguchi M., Oota T., Sakakibara K., Inui N., Fujii G.
Establishment and characterization of a human neuroblastoma cell line in tissue culture.
Jpn. J. Exp. Med. 49:67-83(1979)

DOI=10.1016/B978-0-12-333530-2.50006-X
Israel M.A., Thiele C.J.
Tumor cell lines of the peripheral nervous system.
(In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.43-78; Academic Press; New York (1994)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

PubMed=12702577
Saito-Ohara F., Imoto I., Inoue J., Hosoi H., Nakagawara A., Sugimoto T., Inazawa J.
PPM1D is a potential target for 17q gain in neuroblastoma.
Cancer Res. 63:1876-1883(2003)

PubMed=18923524; DOI=10.1038/nature07399
Chen Y., Takita J., Choi Y.L., Kato M., Ohira M., Sanada M., Wang L., Soda M., Kikuchi A., Igarashi T., Nakagawara A., Hayashi Y., Mano H., Ogawa S.
Oncogenic mutations of ALK kinase in neuroblastoma.
Nature 455:971-974(2008)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections JCRB; JCRB0612
Cell line databases/resources CGH-DB; 79-1
CGH-DB; 9101-4
Cosmic-CLP; 906875
GDSC; 906875
LINCS_LDP; LCL-1974
Ontologies BTO; BTO:0002253
Biological sample resources BioSample; SAMN03471632
Chemistry resources ChEMBL-Cells; CHEMBL3308168
ChEMBL-Targets; CHEMBL2366179
Gene expression databases GEO; GSM313801
GEO; GSM333796
GEO; GSM827274
GEO; GSM1669813
Polymorphism and mutation databases Cosmic; 801735
Cosmic; 906875
Cosmic; 920255
Cosmic; 947701
Cosmic; 1037351
Cosmic; 1099148
Cosmic; 1153780
Cosmic; 2131591